Skip to main content

Table 1 Summary of socio-demographic characteristics of PLHIV and ART adherence at the HIV clinic (2016–2017)

From: Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study

Variable

N (%)

Non-adherence/total (%)

PR [CI 95%]

p value

Age**

30 [24–38.50]

29 [24–39]

 

0.646

Sex

 Male

144 (80.0)

81/144 (56.3)

  

 Female

36 (20.0)

24/36 (66.7)

0.84 [0.64–1.11]

0.257

Sexual orientation

 Homosexual

63 (35.0)

35/63 (55.6)

 

0.853

 Heterosexual

89 (49.4)

53/89 (59.6)

1.07 [0.81–1.42]

 

 Bisexual

28 (15.6)

17/28 (60.7)

1.09 [0.75–1.58]

 

Marital status

 Single

122 (67.8)

68/122 (55.7)

 

0.778

 Living with someone/partner

35 (19.4)

22/35 (62.9)

1.13 [0.84–1.52]

 

 Married

12 (6.7)

8/12 (66.7)

1.20 [0.78–1.84]

 

 Divorced/widowed

11 (6.1)

7/11 (63.6)

1.14 [0.71–1.83]

 

Number of children

 0

115 (63.9)

60/115 (52.2)

 

0.029*

 1

21 (11.7)

13/21 (61.9)

1.19 [0.81–1.73]

 

 2

25 (13.9)

19/25 (76)

1.46 [1.10–1.93]

 

 ≥ 3

19 (10.6)

13/19 (68.4)

1.31 [0.92–1.86]

 

Monthly family incomes**

1000 [625–1500]

1000 [700–1800]

 

0.302

ART prescription

 ZDV + 3TC + EFV

62 (34.4)

39/62 (62.9)

 

0.861

 TDF + 3TC + EFV

47 (26.1)

25/47 (53.2)

0.85 [0.61–1.18]

 

 ABC + 3TC + EFV

26 (14.4)

14/26 (53.8)

0.86 [0.57–1.28]

 

 TDF + 3TC + ATV + RTV

15 (8.3)

9/15 (60)

0.95 [0.61–1.50]

 

 Other

30 (16.7)

18/30 (60)

0.95 [0.67–1.35]

 

Place of diagnosis

 Hospital

95 (52.8)

60/95 (63.2)

 

0.035*

 Primary Health Center

59 (32.8)

32/59 (54.2)

0.86 [0.65–1.14]

 

 Private lab or clinic

16 (8.9)

5/16 (31.3)

0.49 [0.24–1.04]

 

 Ambulatory care

10 (5.6)

8/10 (80)

1.27 [0.90–1.79]

 

Viral Load

   

0.513

  > 40

81 (45.0)

51/81 (63)

 

0.255

  ≤ 40

99 (55.0)

54/99 (54.5)

1.15 [0.90–1.48]

 

Nivel de CD4**

356 [261–527]

362 [264–516]

 

0.879

 ≤ 300

66 (36.7)

37/66 (56.1)

 

0.638

 > 300

114 (63.3)

68/114 (59.6)

0.94 [0.72–1.22]

 

Years with no ART since diagnosis**

2 [1–5]

2 [1–5]

 

0.662

 ≥ 1

45 (25)

26/45 (57.8)

 

0.930

 < 1

135 (75)

79/135 (58.5)

0.99 [0.74–1.32]

 

Years living with HIV**

2 [1–3]

2 [1–3]

 

0.980

 ≥ 1

141 (78.3)

86/141 (61)

 

0.169

 < 1

39 (21.7)

19/39 (48.7)

1.25 [0.88–1.77]

 

Years taking ART**

1 [1, 2]

1 [1, 2]

 

0.988

 ≥ 1

122 (67.8)

73/122 (59.8)

 

0.553

 < 1

58 (32.2)

32/58 (55.2)

1.08 [0.82–1.43]

 

Opportunistic infection

 Yes

80 (44.4)

43/80 (53.8)

 

0.265

 No

100 (55.6)

62/100 (62)

0.87 [0.67–1.12]

Pulmonary tuberculosis

 Yes

18 (10.0)

6/18 (33.3)

 

0.023*

 No

162 (90.0)

99/162 (61.1)

0.55 [0.28–1.06]

Side effects with actual ART prescription

 

 Yes

92 (51.1)

62/92 (67.4)

 

0.012*

 No

88 (48.9)

43/88 (48.9)

1.38 [1.07–1.78]

Action taken with side effects

 

 Ask for medical advice

57 (62.0)

38/57 (66.7)

 

0.031*

 Wait it to stop

28 (30.4)

22/28 (78.6)

1.18 [0.90–1.54]

 Keep taking my ART

4 (4.3)

2/4 (50)

0.75 [0.28–2.03]

 Did not answer

3 (3.3)

0/3 (0)

–

ART abandoned at anytime

 Yes

83 (46.1)

72/83 (86.7)

 

0.001*

 No

97 (53.9)

33/97 (34)

2.55 [1.91–3.41]

Length of ART abandon

 > 30 days

15 (18.1)

9/15 (60)

 

0.001*

 10–30 days

16 (19.3)

14/16 (87.5)

1.46 [0.93–2.29]

 1–9 days

52 (62.7)

49/52 (94.2)

1.57 [1.03–2.39]

Reason for abandonment

 Forgetfulness or neglect when attending a commitment, meeting or work

35 (40.7)

35/35 (100)

 

0.033*

 Bureaucracy to get access to ART

17 (19.8)

13/17 (76.5)

0.76 [0.59–1.00]

 Lack of privacy or feeling better

11 (12.8)

9/11 (81.8)

0.82 [0.62–1.08]

 Fear of side effects

8 (9.3)

6/8 (75)

0.75 [0.50–1.12]

 Others

15 (17.4)

11/15 (73.3)

0.73 [0.54–1.00]

  1. Zidovudine = ZDV; Lamivudine = 3TC; Efavirenz = EFV; Tenofovir = TDF; Abacavir = ABC; Atazanavir = ATV; Ritonavir = RTV; Lopinavir = LPV; PR = prevalence ratio
  2. * p-value < 0.05 ** Mean [IQR]